Each year, an estimated 300,000 adults in the United States die of causes related to obesity [2] According to the guidelines of the National Institute of Health (NIH) regarding the treatment of obesity, weight loss drugs approved by the FDA [US Food and Drug Administration] may only be used as part of a comprehensive weight loss program, including dietary therapy and physical activity, for patients with a BMI [body mass index] of 30 with no concomitant obesity-related risk factors or diseases, and for patients with a BMI of 27 with concomitant obesity-related risk factors or diseases[3].The risk factors and diseases considered important enough to warrant pharmacotherapy at a BMI of 27--29.9 are hypertension, dyslipidemia, coronary heart disease (CHD), type 2 diabetes, and sleep apnea [3]
Both are commonly discussed in relation to tissue repair, musculoskeletal recovery, inflammation, and physical resilience
But that material is only as good as the hands it's in
Where to Inject Different Types of Peptides The recommended injection site may vary based on the peptide being prescribed
Bariatric Surgery Sleeve gastrectomy, gastric bypass, and newer, less invasive procedures produce the largest and most durable weight loss of any intervention
So while early animal data on BPC-157 is indeed fascinating, the lack of human trials means were still very much in the dark
